A 29-week-old male foetus was diagnosed by foetal echocardiography with severe hypertrophic cardiomyopathy with systolic dysfunction and generalized oedema, undergoing a Caesarean section at 33 weeks. Mechanical ventilation and milrinone infusion were required during the first week. Systolic function and output parameters improved progressively. Metabolic and infectious screenings were negative. At the follow-up, during the first year of life, hypertrophy regressed, posterior right auricular hypertrophy evolved to a mass with cysts, and left ventricular myocardium developed trabeculations accomplishing non-compaction criteria. Recently, mutations in genes previously implicated in the pathogenesis of hypertrophic cardiomyopathy have been identified in patients with left ventricular non-compaction without hypertrophy. This report suggests that these cardiomyopathies may have a similar genetic origin, and can co-exist in the same patient.
A 29-week-old male foetus was diagnosed by foetal echocardiography with severe hypertrophic cardiomyopathy with important atrial involvement and moderate systolic dysfunction, undergoing a Caesarean section at 33 weeks. Familiar history was anodyne. Neonatal echocardiography confirmed diagnosis (left ventricular posterior wall, 5.5 mm; septum, 7.5 mm; ejection fraction, 45%). Mechanical ventilation and milrinone infusion were required during the first week. Systolic function and output parameters improved progressively (Figure 1 , Supplementary data, Videos 1 and 2). Metabolic and infectious screenings were negative.
At the follow-up, during the first year of life, the patient developed a mild psychomotor delay with axial hypotony and central respiratory insufficiency requiring home mechanical ventilation. Echocardiographic controls in this first year showed progressive regression of hypertrophy, except at the lateral right auricular wall, where persisted ( Figure 2 , Supplementary data, Video 3). At the same time, left ventricular myocardium developed trabeculations accomplishing left ventricular non-compaction criteria, 1, 2 with no changes in ventricular function (Figure 3 , Supplementary data, Video 4). Familial echocardiographic screening has been negative.
Recently, mutations in genes encoding sarcomeric proteins, which previously have been implicated in the pathogenesis of hypertrophic cardiomyopathy, have been identified in patients with left ventricular non-compaction but without hypertrophic cardiomyopathy (MYH7, ACTC, TNNT2). 3, 4 Initially assumed to be congenital, left ventricular non-compaction in the meantime has been shown to develop during life-time in several cases. 5 Literature has reported the relationship of left ventricular non-compaction and neuromuscular disorders, 4 the co-existence of left ventricular noncompaction and hypertrophic cardiomyopathy in the same family, 5 and patient. 6 Our report shows the overlapping of these two entities and their evolutive and dynamic character. We do not know why hypertrophic cardiomyopathy appeared first and evolved to left ventricular non-compaction, perhaps the presence of systolic foetal heart failure, could have been the trigger to hypertrophy, and after the birth, when systolic function improved, progressive regression of the hypertrophy and evolution to left ventricular non-compaction was observed. Diagnosis of foetal hypertrophic cardiomyopathy
